The BRAF mutation has however been identified in several primary uveal melanoma cell lines and recently Malaponte et al (2006) identified the mutation in one primary uveal melanoma.
The CHEK2*1100delC germline mutation has, however, been found to be linked to one specific allele of the D22S275 polymorphic marker, that is located in intron 4 of CHEK2, which is present in 13% of the Dutch population (Meijers-Heijboer et al, 2002).
Until recently this mutation had however only been identified in one case of posterior uveal melanoma.
Severe loss-of-function ACTH receptor/melanocortin-2-receptor (MC2R) mutations have, however, been associated with mild derangements in the renin angiotensin aldosterone axis (3).
Cancer is an acquired genetic disorder due to an accumulation of gene mutations: it has however become clear that the number of mutations that tumours harbour can be very large, as indeed are present in normal tissues, with a very diverse pattern of mutations even in similar tumours [ 5, 6].
These secondary mutation spectra have, however, been poorly characterized, mainly because studies often focused at one or a few reporter loci, or exclusively on mutations at known hotspot sequences.
For hVAPB, however, such mutations have yet to be identified.
36, 37 The T790M mutation has also been detected, however, in a small proportion of NSCLC patients who have not yet received any treatment.
Early emergence of viral resistance mutations has been, however, associated with PI monotherapy [5], [6], [7], [8], with several of these mutations showing cross-resistance to multiple PI agents [9].
Epitope mapping prediction of PvAMA-1 showed the potential B-cell epitopes across DI DIII overlap with E145K, P210S, R249H, G253E, K352E, R438H and N445D mutations; however, no mutation has been found in intrinsically unstructured/disordered regions.
However, this mutation has created a new subscriber, ready to receive a signal from a publisher, or coding region.
